Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 13, 2020
Grant Date -
Dec 29, 2016
app pub date -
Jun 29, 2016
filing date -
Jun 29, 2015
priority date (Note) -
In Force
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance
Loading Importance Indicators...

Calculated Rating
US Family Size
|
Non-US Coverage
|
Abstract
The present invention relates to compounds and methods which may be useful as treatments of diseases.
First Claim
all claims..Other Claims data not available
Family
Country | kind | publication No. | Filing Date | Type | Sub-Type |
---|
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
- REVERAGEN BIOPHARMA, INC.
International Classification(s)

- 2016 Application Filing Year
- A61K Class
- 19101 Applications Filed
- 13019 Patents Issued To-Date
- 68.16 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Damsker, Jesse | Washington, US | 17 | 45 |
# of filed Patents : 17 Total Citations : 45 | |||
Hoffman, Eric | Kensington, US | 73 | 1890 |
# of filed Patents : 73 Total Citations : 1890 | |||
McCall, John M | Boca Grande, US | 93 | 846 |
# of filed Patents : 93 Total Citations : 846 | |||
Nagaraju, Kanneboyina | Kensington, US | 16 | 131 |
# of filed Patents : 16 Total Citations : 131 |
Cited Art Landscape
- No Cited Art to Display
Loading Cited Art Landscape... 

Patent Citation Ranking
- 5 Citation Count
- A61K Class
- 66.68 % this patent is cited more than
- 5 Age
Forward Cite Landscape
- No Forward Cites to Display
Loading Forward Cite Landscape... 

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Apr 13, 2028 |
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Apr 13, 2032 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text
US Patent Application No: 2016/0375,037
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF DISEASE
Abstract
The present invention relates to compounds and methods which may be useful as treatments of diseases.
Description
Claims
Claims data not available

Legal Events
- No Legal Status data available.

Matter Detail

Country:
Application No:
Patent No:
Application Publication No:
Status:
Priority Date:
Filing Date:
Matter Type:
Local Registration No:
Docket No:
Secondary System Identifier (SSI):
Customer Application No:
Filing Type:
Request for Examination Date:
Parent Filing Date:
Complete Specification Date:
PCT Filing Date:
National Entry Date:
First Publication Date:
Allowance Date:
Grant Date:
Grant Publication Date:
Claims:
Independent Claims:
Law Firm:
Renewals Detail

Applicant:
Applicant ID:
Entity Size:
Renewal Status:
Renewal Base Date:
Renewal Trigger Date: